Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danielle S Cha

Showing results (1-10 of 81) with videos related to

Pageof 9
Sort By:
Expert Opinion on Pharmacotherapy|February 7, 2012
Treatment-emergent adverse events associated with atypical antipsychoticsDanielle S Cha, Roger S McIntyre
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 12, 2012
Predicting treatment response in major depressive disorder: the impact of early symptomatic improvementPaul A Kudlow, Danielle S Cha, Roger S McIntyre
F1000 Biology Reports|July 18, 2012
Crosstalk between metabolic and neuropsychiatric disordersOksana Kaidanovich-Beilin, Danielle S Cha, Roger S McIntyre
CNS Spectrums|November 19, 2013
A review of FDA-approved treatment options in bipolar depressionRoger S McIntyre, Danielle S Cha, Rachael D Kim, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 29, 2014
Inflamed moods: a review of the interactions between inflammation and mood disordersJoshua D Rosenblat, Danielle S Cha, Rodrigo B Mansur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 26, 2012
Selfish brain and neuroprogression in bipolar disorderRodrigo B Mansur, Danielle S Cha, Elson Asevedo, et al.
CNS & Neurological Disorders Drug Targets|December 4, 2014
Gut emotions - mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disordersAnastasiya Slyepchenko, Andre F Carvalho, Danielle S Cha, et al.
Bipolar Disorders|January 29, 2014
Sex differences in rates of obesity in bipolar disorder: postulated mechanismsAnusha Baskaran, Danielle S Cha, Alissa M Powell, et al.
Neuropharmacology|September 21, 2013
Implications of epigenetic modulation for novel treatment approaches in patients with schizophreniaDanielle S Cha, Paul A Kudlow, Anusha Baskaran, et al.
Expert Review of Neurotherapeutics|August 8, 2019
Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorderDanielle S Cha, Xinyi Luo, Juhie Ahmed, et al.
Pageof 9

Showing results (1-10 of 81) with videos related to

Sort By:
Pageof 9
Expert Opinion on Pharmacotherapy|February 7, 2012
Treatment-emergent adverse events associated with atypical antipsychoticsDanielle S Cha, Roger S McIntyre
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie|December 12, 2012
Predicting treatment response in major depressive disorder: the impact of early symptomatic improvementPaul A Kudlow, Danielle S Cha, Roger S McIntyre
F1000 Biology Reports|July 18, 2012
Crosstalk between metabolic and neuropsychiatric disordersOksana Kaidanovich-Beilin, Danielle S Cha, Roger S McIntyre
CNS Spectrums|November 19, 2013
A review of FDA-approved treatment options in bipolar depressionRoger S McIntyre, Danielle S Cha, Rachael D Kim, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 29, 2014
Inflamed moods: a review of the interactions between inflammation and mood disordersJoshua D Rosenblat, Danielle S Cha, Rodrigo B Mansur, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|December 26, 2012
Selfish brain and neuroprogression in bipolar disorderRodrigo B Mansur, Danielle S Cha, Elson Asevedo, et al.
CNS & Neurological Disorders Drug Targets|December 4, 2014
Gut emotions - mechanisms of action of probiotics as novel therapeutic targets for depression and anxiety disordersAnastasiya Slyepchenko, Andre F Carvalho, Danielle S Cha, et al.
Bipolar Disorders|January 29, 2014
Sex differences in rates of obesity in bipolar disorder: postulated mechanismsAnusha Baskaran, Danielle S Cha, Alissa M Powell, et al.
Neuropharmacology|September 21, 2013
Implications of epigenetic modulation for novel treatment approaches in patients with schizophreniaDanielle S Cha, Paul A Kudlow, Anusha Baskaran, et al.
Expert Review of Neurotherapeutics|August 8, 2019
Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorderDanielle S Cha, Xinyi Luo, Juhie Ahmed, et al.
Pageof 9